Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: The SEAS (Simvastatin and ezetimibe in aortic stenosis) study

Journal of the American College of Cardiology

Volumn 59, Issue 13, 2012, Pages 1142-1149

  Greve, Anders M ^a   Gerdts, Eva ^b   Boman, Kurt ^c   Gohlke Baerwolf, Christa ^d   Rossebø, Anne B ^e   Devereux, Richard B ^f   Køber, Lars ^a   Ray, Simon ^g   Willenheimer, Ronnie ^h   Wachtell, Kristian ^a,i  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF BERGEN   (Norway)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

asymptomatic aortic stenosis; QRS duration; sudden cardiac death

Indexed keywords

EZETIMIBE; PLACEBO; SIMVASTATIN;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART BUNDLE BRANCH BLOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORPHOLOGY; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RISK ASSESSMENT; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AZETIDINES; BUNDLE-BRANCH BLOCK; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SIMVASTATIN;

EID: 84858674183     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.12.020     Document Type: Article

References (25)

1. B.A. Carabello Aortic stenosis: from pressure overload to heart failure Heart Fail Clin 2 2006 435 442 (Pubitemid 46590079)
2. A. Vahanian, H. Baumgartner, J. Bax Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 2007 230 268 (Pubitemid 46276943)
3. B.A. Carabello Evaluation and management of patients with aortic stenosis Circulation 105 2002 1746 1750 (Pubitemid 34408877)
4. D.P. Morin, L. Oikarinen, M. Viitasalo QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study Eur Heart J 30 2009 2908 2914
5. R. Dhingra, M.J. Pencina, T.J. Wang Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study Hypertension 47 2006 861 867 (Pubitemid 44297556)
6. R. Dhar, A.A. Alsheikh-Ali, N.A. Estes 3rd Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) Heart Rhythm 5 2008 807 813
7. R. Dhingra, N.B. Ho, E.J. Benjamin Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study J Am Coll Cardiol 45 2005 685 689 (Pubitemid 40278966)
8. C.K. Nair, W.S. Aronow, K. Stokke, S.M. Mohiuddin, W. Thomson, M.H. Sketch Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium Am J Cardiol 53 1984 169 172 (Pubitemid 14217528)
9. A.B. Rossebo, T.R. Pedersen, C. Allen Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study Am J Cardiol 99 2007 970 973 (Pubitemid 46483289)
10. A.B. Rossebo, T.R. Pedersen, K. Boman Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
11. A.M. Greve, E. Gerdts, K. Boman Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data) Am J Cardiol 108 2011 541 547
12. R.J. Prineas, R.S. Crowe, H. Blackburn The Minnesota Code Manual of Electrocardiographic Findings 1982 John Wright Bristol
13. D. Cramariuc, G. Cioffi, A.E. Rieck Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy J Am Coll Cardiol Img 2 2009 390 399
14. H. Baumgartner, J. Hung, J. Bermejo Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice Eur J Echocardiogr 10 2009 1 25
15. R.M. Lang, M. Bierig, R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
16. J.P. Fine, R.J. Gray A proportional hazard model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
17. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 (Pubitemid 351193639)
18. S.S. Chugh, J. Jui, K. Gunson Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community J Am Coll Cardiol 44 2004 1268 1275 (Pubitemid 39208884)
19. H. Greenberg, R.B. Case, A.J. Moss, M.W. Brown, E.R. Carroll, M.L. Andrews Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) J Am Coll Cardiol 43 2004 1459 1465 (Pubitemid 38496355)
20. A.L. Goldberger, V. Bhargava QRS duration measurement using high-frequency electrocardiography: applications and limitations of a new technique Comput Biomed Res 15 1982 474 484 (Pubitemid 13215735)
21. M.K. Das, H. Suradi, W. Maskoun Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis Circ Arrhythm Electrophysiol 1 2008 258 268
22. T. Nagai, T. Kurita, K. Satomi QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy Circ J 73 2009 1028 1032
23. V.S. Kasi, H.D. Xiao, L.L. Shang Cardiac-restricted angiotensin- converting enzyme overexpression causes conduction defects and connexin dysregulation Am J Physiol Heart Circ Physiol 293 2007 H182 H192
24. A.E. Rieck, D. Cramariuc, E.M. Staal, A.B. Rossebo, K. Wachtell, E. Gerdts Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy) J Hypertens 28 2010 377 383
25. A.L. Aro, O. Anttonen, J.T. Tikkanen Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population Circ Arrhythm Electrophysiol 4 2011 705 710